Aprogen Subsidiary Amends Paid-in Capital Increase
에이프로젠
007460
Signal Score
Historical Avg Return (5d)
+0.33%
Data Coverage
100%n=2377
Risk-adjusted indicator based on 2377 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • New Shares Issued: 20,181,000 Shares (Amended from 21,000,000 Shares)
- • Par Value per Share: 1,000 KRW (Amended from 100 KRW)
- • Issue Price per Share: 1,000 KRW (Amended from 961 KRW)
- • Total Funding: 20,181,000,000 KRW
- • Pre-Dilution Shares: 19,658,914 Shares (Amended from 193,582,040 Shares)
AI Analysis Summary
Aprogen's subsidiary, Aptn Inc., amended its third-party allotment paid-in capital increase. The number of new shares to be issued was adjusted to 20,181,000 shares (from 21,000,000 shares), with the par value and issue price both set at 1,000 KRW per share (previously 100 KRW and 961 KRW, respectively). The total capital raised for operations is 20.181 billion KRW. The pre-dilution outstanding shares were significantly corrected from 193,582,040 to 19,658,914 shares. This capital increase will result in a substantial dilution of approximately 102.66% for existing shareholders (20,181,000 new shares / 19,658,914 existing shares), primarily for new business operations. The issuance price of 1,000 KRW is higher than the amended reference price of 799 KRW, which is positive, but the overall dilution is significant.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.